New Delhi, August 27:슬롯 머신 사이트 추천Adar Poonawalla, CEO of Serum Institute of India (SII) on Thursday슬롯 머신 사이트 추천requested media to refrain from슬롯 머신 사이트 추천reporting on interim data coming in about patients on Covishield clinical trials. Taking to Twitter,슬롯 머신 사이트 추천 Poonawalla urged people to슬롯 머신 사이트 추천respect the trial process and stay patient for two months. He assured that슬롯 머신 사이트 추천relevant data on슬롯 머신 사이트 추천Covishield clinical trials슬롯 머신 사이트 추천will be published soon.

"I would kindly request the media to refrain, from reporting on interim data coming in about patients on the SII-Covishield clinical trials. Let us not bias the process. Let us respect the process and stay patient for two months, all the relevant data will be published soon",슬롯 머신 사이트 추천Poonawalla tweeted.슬롯 머신 사이트 추천COVID-19 Vaccine Update: 'Covishield' of Oxford-Astrazeneca and Serum Institute Possibly India's 1st Shot, Release Likely by 2020-End.

Here's the tweet:

In India, the슬롯 머신 사이트 추천Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two males, aged 28 and 48, in Pune's Bharti Vidyapeeth's Medical College and Hospital. In India, a total of 25슬롯 머신 사이트 추천volunteers will be given the dosage in the coming days and a total of 100 volunteers will be enrolled throughout India.슬롯 머신 사이트 추천COVID-19 Vaccine 'Covishield' to be Available in 73 Days? Serum Institute of India Calls Media Reports False and Conjectural.

Medical Director of the medical college Dr Sanjay Lalwani was quoted by IANS saying that two슬롯 머신 사이트 추천volunteers were given 0.5 ml of the vaccine, observed for half an hour to see if they get any local site reaction or systemic reaction. "After half an hour, they were sent home and given an emergency helpline number. They will be observed for seven days", he added.

(The above story first appeared on LatestLY on Aug 27, 2020 02:22 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).